The role of surfactant on chronic infant lung disease

L. J. I. Zimmermann (Capelle, The Netherlands)

Source: Annual Congress 2003 - Chronic infant lung disease
Session: Chronic infant lung disease
Session type: Assembly Symposium
Number: 3296
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. J. I. Zimmermann (Capelle, The Netherlands). The role of surfactant on chronic infant lung disease. Annual Congress 2003 - Chronic infant lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of infection in the development of chronic lung disease of prematurity
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007


Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021



The role of anti-proteases in the development of chronic lung disease of prematurity (CLD)
Source: Annual Congress 2007 - Chronic lung disease of prematurity: pathogenesis and outcomes
Year: 2007


The role of proteases in the development of chronic lung disease of prematurity (CLD)
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007

Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020


The impact of COVID-19 on children with chronic suppurative lung disease
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Source: Eur Respir Monogr 2017; 77: 224-246
Year: 2017


Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease
Source: Breathe, 16 (1) 190319; 10.1183/20734735.0319-2019
Year: 2020



The role of the tracheal phonography in chronic obstructive lung disease and asthma diagnosis
Source: Annual Congress 2012 - Asthma management
Year: 2012

The role of ASC signalling in preterm infants at risk of chronic lung disease of prematurity
Source: International Congress 2018 – Prematurity and lung disease
Year: 2018



Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011



Impact of prematurity on rabbit lung development: a key factor for mimicking chronic neonatal lung disease
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Effects of lung development on pulmonary function tests: from early life to chronic respiratory disease
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020


Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


The association between serum osmolality and lung function among adults
Source: Eur Respir J 2008; 32: 98-104
Year: 2008



Task force on chronic interstitial lung disease in immunocompetent children
Source: Eur Respir J 2004; 24 : 686-697
Year: 2004



Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011